Related Experiment Videos
Preinduction cervical priming with oral prostaglandin E2
American Journal of Obstetrics and Gynecology
|December 15, 1979
Summary
Prostaglandin E2 (PGE2) tablets improved cervical ripeness before labor induction in women. While effective, longer administration may yield better results without significant side effects.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Cervical ripeness is crucial for successful labor induction.
- Prostaglandin E2 (PGE2) is a commonly used agent for cervical ripening.
Purpose of the Study:
- To evaluate the efficacy of 1.0 mg PGE2 tablets in improving cervical ripeness prior to labor induction.
- To assess the safety and side effects of PGE2 administration in this context.
Main Methods:
- Seventy-three women (primigravidas and multigravidas) received 1.0 mg PGE2 tablets hourly for 5 doses.
- Cervical ripeness was assessed based on an initial cervical score.
Main Results:
- The overall response to PGE2 treatment was dependent on the initial cervical score.
- Gastrointestinal side effects were infrequent.
- No complications were observed for mother or fetus.
Conclusions:
- The used PGE2 protocol significantly improved cervical favorability.
- Prolonged PGE2 administration may potentially lead to enhanced cervical ripening.
- PGE2 appears to be a safe option for cervical ripening before labor induction.